Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.

Nov 9, 2022 | Blog, Case Study, CenExel, CenExel CNS, Clinical Trial, Medical Specialties, News, Research Trials, Schizophrenia

Download the Abstract

 

 

Translate »